{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:14:29Z","timestamp":1771668869151,"version":"3.50.1"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013094","name":"Science and Technology Planning Social Development Project of Zhenjiang City","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction and objectives<\/jats:title><jats:p>Recent studies have indicated a potential association of hypertension with Hashimoto\u2019s thyroiditis (HT) and other autoimmune diseases, yet the impact of antihypertensive drugs on HT risk is not well understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We employed a drug-target Mendelian randomization approach to investigate the prolonged impact of 9 classes of antihypertensive medications on HT susceptibility in European and Asian populations. Genetic variants close to or within genes associated with the drug targets and systolic blood pressure (SBP) were utilized to mimic the effects of antihypertensive medications. We focused on drugs linked to a lower risk of coronary artery disease for our main analysis. We gathered genetic data on SBP and HT risk from comprehensive genome-wide association studies available for European and Asian groups. For a supplementary analysis, we used expression quantitative trait loci (eQTLs) related to drug target genes as proxies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our analysis revealed that the use of calcium channel blockers (CCBs) is linked to a reduced risk of HT in both European (OR [95% CI]: 0.96 [0.95 to 0.98] per 1 mmHg decrease in SBP; p = 3.51\u00d710<jats:sup>-5<\/jats:sup>) and Asian populations (OR [95% CI]: 0.28 [0.12, 0.66]; p = 3.54\u00d710<jats:sup>-3<\/jats:sup>). Moreover, genetically mimicking the use of loop diuretics (OR [95% CI]: 0.94 [0.91, 0.97]; p = 3.57\u00d710<jats:sup>-5<\/jats:sup>) and thiazide diuretics (0.98 [0.96, 0.99]; p = 3.83\u00d710<jats:sup>-3<\/jats:sup>) showed a significant association with a decreased risk of HT only in European population. These outcomes were confirmed when eQTLs were employed to represent the effects of antihypertensive medications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The study suggests that CCBs and diuretics could potentially reduce the risk of HT in different populations. Additional research is needed to assess the feasibility of repurposing antihypertensive medications for the prevention of HT.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1419346","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T04:21:16Z","timestamp":1728274876000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Causal relationship between antihypertensive drugs and Hashimoto\u2019s thyroiditis: a drug-target Mendelian randomization study"],"prefix":"10.3389","volume":"15","author":[{"given":"Bing","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengcheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoming","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuehua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.03051.x","article-title":"Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS)","volume":"68","author":"Leese","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9703-2","article-title":"The incidence and prevalence of thyroid autoimmunity","volume":"42","author":"McLeod","year":"2012","journal-title":"Endocrine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02016-0","article-title":"Hyperthyroidism","volume":"403","author":"Chaker","year":"2024","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2990","article-title":"Hashimoto's thyroiditis, risk of coronary heart disease, and L-thyroxine treatment: a nationwide cohort study","volume":"100","author":"Chen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.597","article-title":"Cancer risk in patients with Hashimoto's thyroiditis: a nationwide cohort study","volume":"109","author":"Chen","year":"2013","journal-title":"Br J Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-012-8302-x","article-title":"Genetic and epigenetic mechanisms in thyroid autoimmunity","volume":"54","author":"Hasham","year":"2012","journal-title":"Immunol Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240198","article-title":"Anti-thyroid peroxidase antibody and subclinical hypothyroidism in relation to hypertension and thyroid cysts","volume":"15","author":"Shimizu","year":"2020","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2174\/1871530320666200624163035","article-title":"Serum thyroid peroxidase antibody level and incident hypertension in Iranian men: A suggestion for the role of thyroid autoimmunity","volume":"20","author":"Tohidi","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346501","article-title":"Systolic pulmonary artery pressure and echocardiographic measurements in patients with euthyroid Hashimoto's thyroiditis","volume":"32","author":"Sahin","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2018.1555115","article-title":"The impact of familial predisposition on the development of Hashimoto's thyroiditis","volume":"75","author":"Kust","year":"2020","journal-title":"Acta Clin Belg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2016.31.2.213","article-title":"Clinical relevance of environmental factors in the pathogenesis of autoimmune thyroid disease","volume":"31","author":"Wiersinga","year":"2016","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2001.280.5.H2061","article-title":"Thyroid status influences baroreflex function and autonomic contributions to arterial pressure and heart rate","volume":"280","author":"Foley","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ando.2011.05.004","article-title":"Arterial hypertension and thyroid disorders: what is important to know in clinical practice","volume":"72","author":"Mazza","year":"2011","journal-title":"Ann Endocrinol (Paris)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.07.008","article-title":"Excess iodine promotes apoptosis of thyroid follicular epithelial cells by inducing autophagy suppression and is associated with Hashimoto thyroiditis disease","volume":"75","author":"Xu","year":"2016","journal-title":"J Autoimmun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.3390\/ijms22105074","article-title":"Autophagy and mitophagy promotion in a rat model of endometriosis","volume":"22","author":"Siracusa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1291\/hypres.28.689","article-title":"Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine","volume":"28","author":"Toba","year":"2005","journal-title":"Hypertens Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3109\/10641960903254414","article-title":"Anti-inflammatory properties of azelnidipine, a dihydropyridine-based calcium channel blocker","volume":"32","author":"Komoda","year":"2010","journal-title":"Clin Exp Hypertens"},{"key":"B19","article-title":"Effects of diuretic therapy on electrolyte and acid-base homeostasis","volume":"146","author":"Mayer","year":"1996","journal-title":"Wien Med Wochenschr"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15205","article-title":"Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure","volume":"76","author":"Wilcox","year":"2020","journal-title":"Hypertension"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl019","article-title":"Inflammation and hypertension: the search for a link","volume":"21","author":"Pauletto","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"B22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/01.hyp.38.3.399","article-title":"Blood pressure and inflammation in apparently healthy men","volume":"38","author":"Chae","year":"2001","journal-title":"Hypertension"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200310000-00010","article-title":"Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures","volume":"21","author":"Schillaci","year":"2003","journal-title":"J Hypertens"},{"key":"B24","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/01.hjh.0000166840.63312.12","article-title":"Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension","volume":"23","author":"Stumpf","year":"2005","journal-title":"J Hypertens"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpaa195","article-title":"Mechanisms of vascular remodeling in hypertension","volume":"34","author":"Humphrey","year":"2021","journal-title":"Am J Hypertens"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1042\/CS20220797","article-title":"Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation","volume":"138","author":"Toton-Zuranska","year":"2024","journal-title":"Clin Sci (Lond)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.07.091","article-title":"Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies","volume":"94","author":"Patel","year":"2017","journal-title":"BioMed Pharmacother"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvn050","article-title":"Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone","volume":"78","author":"Bakker","year":"2008","journal-title":"Cardiovasc Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"a040501","DOI":"10.1101\/cshperspect.a040501","article-title":"Mendelian randomization: concepts and scope","volume":"12","author":"Richmond","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyu176","article-title":"Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways","volume":"44","author":"Burgess","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz155","article-title":"Repurposing antihypertensive drugs for the prevention of Alzheimer's disease: a Mendelian randomization study","volume":"49","author":"Walker","year":"2020","journal-title":"Int J Epidemiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0205-x","article-title":"Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits","volume":"50","author":"Evangelou","year":"2018","journal-title":"Nat Genet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003897","article-title":"Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis","volume":"19","author":"Yarmolinsky","year":"2022","journal-title":"PLoS Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.312086","article-title":"Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease","volume":"122","author":"van der Harst","year":"2018","journal-title":"Circ Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1446","article-title":"The impact of hypertension and use of calcium channel blockers on tuberculosis treatment outcomes","volume":"73","author":"Chidambaram","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neulet.2013.08.004","article-title":"Voltage gated sodium and calcium channel blockers for the treatment of chronic inflammatory pain","author":"Rahman","year":"2013","journal-title":"Neurosci Lett"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1159\/000366313","article-title":"Anoctamin 1 is apically expressed on thyroid follicular cells and contributes to ATP- and calcium-activated iodide efflux","volume":"34","author":"Iosco","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03526","article-title":"Ca(2+) signaling in T lymphocytes: the interplay of the endoplasmic reticulum, mitochondria, membrane potential, and CRAC channels on transcription factor activation","volume":"6","author":"Yang","year":"2020","journal-title":"Heliyon"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707538","article-title":"Effects of angiotensin II blockade on inflammation-induced alterations of pharmacokinetics and pharmacodynamics of calcium channel blockers","volume":"153","author":"Hanafy","year":"2008","journal-title":"Br J Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e4818","DOI":"10.7554\/eLife.48118","article-title":"Novel charged sodium and calcium channel inhibitor active against neurogenic inflammation","volume":"8","author":"Lee","year":"2019","journal-title":"Elife"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.200311","article-title":"L-type calcium channel blockers exert an antiinflammatory effect by suppressing expression of plasminogen receptors on macrophages","volume":"105","author":"Das","year":"2009","journal-title":"Circ Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/ajh.2007.13","article-title":"Calcium channel blockers suppress cytokine-induced activation of human neutrophils","volume":"21","author":"Shima","year":"2008","journal-title":"Am J Hypertens"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e3283463e5b","article-title":"Calcium channel blockers and modulation of innate immunity","volume":"24","author":"Liu","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2013.05.008","article-title":"Calcium, channels, intracellular signaling and autoimmunity","volume":"10","author":"Izquierdo","year":"2014","journal-title":"Reumatol Clin"},{"key":"B49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-immunol-032414-112212","article-title":"Ion channels in innate and adaptive immunity","volume":"33","author":"Feske","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-023-01931-5","article-title":"Sodium homeostasis and hypertension","volume":"25","author":"Aung","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3109\/10641960902929438","article-title":"Spironolactone and chlorthalidone in uncontrolled elderly hypertensive patients treated with calcium antagonists and angiotensin II receptor-blocker: effects on endothelial function, inflammation, and oxidative stress","volume":"31","author":"Yamanari","year":"2009","journal-title":"Clin Exp Hypertens"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102786","article-title":"Risk factors for hypertension in rheumatoid arthritis patients-A systematic review","volume":"20","author":"Hadwen","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000736","article-title":"Initiation of disease-modifying therapies in rheumatoid arthritis is associated with changes in blood pressure","volume":"24","author":"Baker","year":"2018","journal-title":"J Clin Rheumatol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-019-0914-2","article-title":"Autoimmune disease-associated hypertension","volume":"21","author":"Wolf","year":"2019","journal-title":"Curr Hypertens Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102371","article-title":"Systemic lupus erythematosus and hypertension","volume":"18","author":"Munguia-Realpozo","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-5174.2007.00004.x","article-title":"Drugs to treat systemic lupus Erythematosus: relationship between current use and cardiovascular risk factors","volume":"1","author":"Rho","year":"2008","journal-title":"Arch Drug Inf"},{"key":"B57","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.amjmed.2022.11.016","article-title":"Renin-angiotensin system-modifying antihypertensive drugs can reduce the risk of cardiovascular complications in lupus: A retrospective cohort study","volume":"136","author":"Hurst","year":"2023","journal-title":"Am J Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1024120","article-title":"Efficacy and safety of dietary polyphenols in rheumatoid arthritis: A systematic review and meta-analysis of 47 randomized controlled trials","volume":"14","author":"Long","year":"2023","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000522","article-title":"Drug-induced lupus erythematosus: an update on drugs and mechanisms","volume":"30","author":"He","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-022-00288-2","article-title":"The genetic landscape of major drug metabolizing cytochrome P450 genes-an updated analysis of population-scale sequencing data","volume":"22","author":"Zhou","year":"2022","journal-title":"Pharmacogenomics J"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12771","article-title":"Pharmacogenomics in Asian subpopulations and impacts on commonly prescribed medications","volume":"13","author":"Lo","year":"2020","journal-title":"Clin Transl Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13073-017-0502-5","article-title":"Genetic variation in human drug-related genes","volume":"9","author":"Scharfe","year":"2017","journal-title":"Genome Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1419346\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T04:21:20Z","timestamp":1728274880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1419346\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":62,"alternative-id":["10.3389\/fendo.2024.1419346"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1419346","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,7]]},"article-number":"1419346"}}